Sleisenger M H, Fordtran J S. Gastrointestinal disease: pathophysiology, diagnosis, management[M]. 5th ed. WB Saunders:Philade phia, 1993, 977.
[2]
Nordin B E. Calcium and osteoporosis[J]. Nutrition, 1997, 13:664.
[3]
Johnson J A, Kumar R. Renal and intestinal calcium transport: roles of vitamin D-dependent calcium binding proteins[J]. Semin Nephrol, 1994, 14:119.
[4]
Wasserman R H, Chandler J S, Meyer S A, et al. Intestinal calcium transport and calcium extrusion processes at the basolateral membrane[J]. J Nutr, 1992, 122: 662.
[5]
Clark I. Relation of magnesium ions to calcium and phosphate absorption[J]. Nature, 1965, 207: 982.
[6]
Gallagher J C, Riggs B L, Eisman J, et al. Intestinal calcium absorption and serum vitamin D metabolites in normal subjects and osteoporotic patients [J]. J Clin Invest, 1979, 64:729.
[7]
Gallagher J C, Riggs B L, DeLuca H F. Effect of estrogen on calcium absorption and serum vitamin D metabolites in postmenopausal osteoporosis[J]. J Clin Endocrinol Metab, 1980, 51:1359.
[8]
Francis R M, Peacock M, Taylor G A, et al. Calcium malabsorption in elderly women with vertebral fractures: evidence for resistance to the action of vitamin D metabolites on the bowel[J]. Clin Sci, 1984, 66:103.
[9]
Morris H A, Need A G, Horowitz M, et al. Calcium absorption in normal and osteoporotic postmenopausal women[J]. Calcif Tissue Int, 1991, 49:240.
[10]
Kalu D N, Liu C C, Hardin R R, et al. The aged rat model of ovarian hormone deficiency bone loss[J]. Endocrinology, 1989, 124: 7.
[11]
O\'Lounghlin P D, Morris H A. Oophorectomy in young rats impairs calcium balance by increasing int est inal calcium secretion[J]. J Nutr, 1994, 124: 726.
[12]
Kalu D N, Chen C. Ovariectomized murine model of postmenopausal calcium malabsorption[J]. J Bone Miner Res, 1999, 14: 593.
[13]
樊薇.正常人和骨质疏松患者的肠钙吸收[J].中国骨质疏松杂志,1996,2(1): 48.
[14]
Nordin B E, Horowitz M, Need A, et al. Renal leak of calcium in post-menopausal osteoporosis[J]. Clin Endocrinol (Oxf), 1994, 41:41.
[15]
Heshmati H M, Khosla S, Burritt M F, et al. A defect in renal calcium conservation may contribute to the pathogenesis of postmenopausal osteoporosis[J]. J Clin Endocrinol Metab, 1998, 83:1916.
[16]
Caniggia A, Gennari C, Berrello G, et al. Intestinal absorption of calcium-47 after treatment with oral oestrogens-gestogens in senile osteoporosis[J]. Br Med J, 1970, 4:30.
[17]
Civitelli R, Agnusdei D, Nardi P, et al. Effects of one year treatment with estrogens on bone mass, intestinal calcium absorption, and 25-hydroxyvitamin D-1-hydroxylase reserve in postmenopausal osteoporosis[J]. Calcif Tissue Int, 1988, 42:77.
[18]
Gennari C, Agnusdei D, Nardi P, et al. Estrogen preserves a normal intestinal responsiveness to 1,25-dihydroxyvitamin D3 in oophorectomized women[J]. J Clin Endocrinol Metab, 1990, 71:1288.
[19]
Writing Group for the Women\'s Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women\'s health initiative randomized controlled trial[J]. J Ame Med Assoc, 2002, 288:321.
[20]
Siu W S, Qin L, Cheung W H, et al. A study of trabecular bones in ovariectomiezed goats with micro-computed tomography and peripheral quantitative computed tomography[J]. Bone, 2004, 35:21.
[21]
Zhang G, Qin L, Shi Y. Epimedium-derived phytoestrogen flavonoids exert beneficial effect on preventing progress of postmenopausal osteoporosis: A 24-month randomized, double-blind and placebo-controlled trial[J]. J Bone Miner Res, 2007, 22:1072.
[22]
Zhu H M, Qin L, Garnero P, et al. The first multicenter and randomized clinical trial of herbal Fufang for treatment of postmenopausal osteoporosis[J]. Osteoporosis Int, 2012, 23:1327.
[23]
Qin L, Zhang G, Hung W Y, et al. Phytoestrogen-rich formula "XLGB" prevents OVX -induced deterioration of musculoskeletal tissues at hip in old rats[J]. J Bone Miner Metabol, 2005, 23:55.
[24]
Zhang G, Qin L, Hung W Y, et al. Flavonoids derived from Herbal Epimedium Brevicornum Maxim prevent OVX-induced osteoporosis in rats independent of its enhancement in intestinal calcium absorption[J]. Bone, 2006, 38:818.
[25]
Peng S L, Zhang G, He Y X, et al. Epimedium-derived flavonoids promote osteoblastogenesis and suppress adipogenesis in bone marrow stromal cells while exerting an anabolic effect on osteoporotic bone[J]. Bone, 2009, 45:534.
[26]
Zhang J F, Li G, Chan C Y, et al. Flavonoids of herba epimedii regulate osteogenesis of human mesenchymal stem cells through BMP and wnt/beta-catenin signaling pathway[J]. Mol Cell Endocrinol, 2010, 314: 70.
Xie J H, Dick I M, Xu M, et al. The regulation of Chinese herbal medicines on plasma membrane cal ciumpump activity in kidney cells. Western Australia:proceedings of the combined biological science meeting (1999 10th annual meeting), 1999.
Arnaud C D, Sanchez S D. The role of calcium in osteoporosis[J]. Annu Rev Nutr, 1990, 10:397.
[39]
Shea B, Wells G, Cranney A, et al. Meta-analysis of calcium supplementation for the prevention of postmenopausal osteoporosis[J]. Endocr Rev, 2002, 23:552.
[40]
Nieves J W, Komar L, Cosman F, et al. Calcium potentiates the effect of estrogen and calcitonin on bone mass: review and analysis[J]. Am J Clin Nutr, 1998, 67:18.
